Clinical Trials Browser

Phase 4 × Lymphoma, Extranodal NK-T-Cell × Lenalidomide × Clear all

NCT04038411 2019-07-30

PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma

Phase 4 Unknown

Lymphoma, Extranodal NK-T-Cell